Cramer’s Speculative Biotech Play: Regeneron

[cnbc 3000066563]

Len Schleifer, Regeneron Pharmaceuticals CEO, discusses smart biotech investing and growth prospects in the company’s pipeline, with Mad Money’s Jim Cramer.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.